Cases & Deals

Faron Pharmaceuticals completes IPO on AIM

Clients Faron Pharmaceuticals Oy

Jones Day advised Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection with its initial public offering of Ordinary Shares on the Alternative Investment Market (AIM). Cairn Financial Advisors acted as nominated advisor and Whitman Howard Limited acted as nominated broker.